It has been reported that IL-6 released by drug-resistant hepatocellular cancer promotes the expansion and activity of MDSCs, and the interactions between IL-6 and MDSCs promote the chemoresistance of hepatocellular cancer. This evidence concerns the gene IL6 and hepatocellular carcinoma.